The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

<p>Concomitant medication (CM) use may result in Phase I cancer clinical trial ineligibility due to concern for potential CM-investigational drug interactions or alteration of investigational drug absorption. Few studies have examined the impact of CM use on trial eligibility. <b>Methods...

Full description

Bibliographic Details
Main Author:	Mitesh J. Borad, Kelly K. Curtis, Hani M. Babiker, Martin Benjamin, Raoul Tibes, Ramesh K. Ramanathan, Karen Wright, Amylou C. Dueck, Gayle Jameson, Daniel D. Von Hoff
Format:	Article
Language:	English
Published:	Ivyspring International Publisher 2012-01-01
Series:	Journal of Cancer
Online Access:	http://www.jcancer.org/v03p0345.htm

Similar Items

Marantic Endocarditis Associated with Pancreatic Cancer: A Case Series
by: Gayle S. Jameson, et al.
Published: (2009-04-01)

18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer
by: Ronald L. Korn, et al.
Published: (2017-08-01)

Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
by: Glen J. Weiss, et al.
Published: (2011-12-01)

Immunotherapy in pancreatic cancer treatment: a new frontier
by: Komal Thind, et al.
Published: (2017-01-01)

RNA INTERFERENCE (RNAI): AN EFFECTIVE WAY TO DEVELOP RATIONAL COMBINATION THERAPIES WITH HYPOMETHYLATING AGENTS IN ACUTE LEUKAEMIAS AND MYELODYSPLASTIC SYNDROME
by: Raoul Tibes
Published: (2013-08-01)

Introducing the PLOS collection on rare cancer.
by: Mitesh J Borad
Published: (2024-01-01)

Population‐level evidence of survival benefits of patient‐reported outcome symptom monitoring software systems in routine cancer care
by: Ethan Basch, et al.
Published: (2020-11-01)

Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia
by: Douglas Tremblay, et al.
Published: (2021-02-01)

Sick Enough? Mental Illness and Service Eligibility for Homeless Individuals at the Border
by: Curtis Smith, et al.
Published: (2020-08-01)

Is Eligible to Be Indexed in MEDLINE?
by: Sun Huh
Published: (2018-12-01)

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities
by: Dueck Amylou C, et al.
Published: (2011-08-01)

An Eligible Bachelor: Austen, Love, and Marriage in 'Pride and Prejudice' and 'Eligible' by Curtis Sittenfeld
by: Carmen Gomez-Galisteo
Published: (2022-10-01)

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
by: Holly L. Geyer, et al.
Published: (2015-01-01)

Oncolytic Adenoviruses in Gastrointestinal Cancers
by: Raquel T. Yokoda, et al.
Published: (2018-03-01)

Exploring Concomitant Acetylcholinesterase Inhibitor and Overactive Bladder Anticholinergic Use and Risk of Hospitalization in Medicare and Dual-Eligible Medicare–Medicaid Populations in a Historic Database
by: Jonathan H. Watanabe, et al.
Published: (2023-09-01)

Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials
by: Christopher H. Bailey, Gayle Jameson, Chao Sima, Sharon Fleck, Erica White, Daniel D. Von Hoff, Glen J. Weiss
Published: (2012-01-01)

Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease
by: Gry A. Taarnhøj, et al.
Published: (2020-05-01)

Director Eligibility: Corporations and AI
by: Daisuke ASAOKA
Published: (2024-11-01)

Use of outpatient care in VA and Medicare among disability-eligible and age-eligible veteran patients
by: Liu Chuan-Fen, et al.
Published: (2012-03-01)

Patina of precision: risk models for lung cancer screening eligibility
by: Peter B Bach, et al.
Published: (2025-01-01)

Eligibility screening in evidence synthesis of environmental management topics
by: Geoff K. Frampton, et al.
Published: (2017-09-01)

Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
by: Minji K. Lee, et al.
Published: (2023-07-01)

Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
by: Minji K. Lee, et al.
Published: (2020-12-01)

Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
by: Minji K. Lee, et al.
Published: (2021-02-01)

Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research
by: Jennifer Huberty, et al.
Published: (2019-06-01)

Lung Cancer Care Before and After Medicare Eligibility
by: Marco D. Huesch MBBS, PhD, et al.
Published: (2016-05-01)

Prostate Cancer Care Before and After Medicare Eligibility
by: Marco D. Huesch MBBS, PhD, et al.
Published: (2016-04-01)

Data on Medicare eligibility and cancer screening utilization
by: Christian P. Meyer, et al.
Published: (2016-06-01)

Eligibility for partial breast radiotherapy in England
by: Taylor, CW, et al.
Published: (2019)

Drafting eligible biotech and immunotherapy claims
by: Shyh-Jen Wang
Published: (2019-11-01)

El Chucurí elige la vida
by: Miguel Andrés Ramos Jaimes
Published: (2011-01-01)

Pediatric urology: Development, eligibility, practice
by: Bajpai M
Published: (2009-01-01)

Medical eligibility criteria for contraceptive use
by: Ma. del Carmen Cravioto Galindo
Published: (2016-01-01)

Perspectives of primary care providers regarding multicancer early detection panels
by: Benjamin E. Ueberroth, et al.
Published: (2024-08-01)

Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care
by: Curtis Lesley H, et al.
Published: (2003-01-01)

Clinical researchers’ insights on key data for eligibility screening in clinical studies
by: Betina Idnay, et al.
Published: (2024-01-01)

Eligible-and-enrolled vs. eligible-but-not-enrolled patients with chronic ischaemic heart failure in randomized clinical trials of myocardial regeneration
by: Łukasz Czyż, et al.
Published: (2022-11-01)

Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies
by: Ani C. Khodavirdi, et al.
Published: (2024-08-01)

Quality of care for dual eligible beneficiaries in the oncology care model
by: Xinyu Liang, et al.
Published: (2024-07-01)

Analysis of eligibility criteria in Alzheimer’s and related dementias clinical trials
by: Alexandra K. Mitchell, et al.
Published: (2024-07-01)